News

Kilroy Realty Corporation's 2024 Financial Summary & Outlook

Kilroy Realty Corporation's 2024 Financial Summary & Outlook

Kilroy Realty Corporation Financial Performance Overview

Kilroy Realty Corporation (NYSE: KRC) has recently announced its impressive financial results for the fourth quarter and the entire year. The company marked a noticeable increase in revenues, resulting from accelerated leasing activities and other strategic initiatives undertaken throughout the year.

Fourth Quarter Highlights

Strong Revenue Growth

In the fourth quarter, Kilroy achieved revenues of $286.4 million, which shows a marked increase compared to $269.0 million from the same quarter the previous year. This growth in revenue is attributed to robust leasing activities across their West Coast properties.

Net Income Improvements

The net income available for common stockholders reached $59.5 million, translating to $0.50 per diluted share, indicating a significant rise from $47.3 million and $0.40 per share during the same period last year. Such performance reflects the company’s resilience and effective management amidst evolving market conditions.

Leasing and Occupancy Metrics

Leasing Activity Surge

Kilroy reported an impressive total of 708,000 square feet in signed leases during the fourth quarter. This marks the highest quarterly leasing volume since 2019, showcasing an accelerated recovery across their stabilized portfolio, which stood at 82.8% occupied and 84.9% leased by year-end.

Renewal and Renewal Leasing

Significantly, the leasing activities consisted of 206,000 square feet of new leases on previously vacant spaces and 356,000 square feet in currently occupied properties, alongside 146,000 square feet of renewal leases. This diverse leasing strategy has contributed to the growing occupancy rates across Kilroy’s properties.

Investment and Financial Strategy

Strategic Investments

In a bid to harness more technological efficiencies, Kilroy committed to investing in a PropTech venture capital fund managed by Fifth Wall. This move highlights the corporation's dedication to innovation and optimizing its operational capacity.

Corporate Asset Sales

In November, the company sold its corporate aircraft for approximately $19.8 million, resulting in a gain of roughly $6.0 million or $0.05 per diluted share, further strengthening its balance sheet.

Annual Summary of 2024

Yearly Financial Results

Kilroy reported total revenues for the fiscal year of $1,135.6 million, a slight increase over $1,129.7 million in 2023. The net income for the year was $211.0 million, or $1.77 per diluted share, slightly down from $212.2 million and $1.80 per share in the previous year. Funds from operations also saw an annual rise to $551.6 million or $4.59 per diluted share.

Leasing Achievement

Throughout the year, Kilroy signed approximately 1,778,000 square feet of leases, representing the highest annual leasing volume since 2019. This included a significant 536,000 square feet of new leasing on previously vacant spaces, showcasing Kilroy’s strong performance relative to market demands.

Sustainability Commitment

Kilroy Realty continues to pride itself on its environmental sustainability efforts. The company has been recognized for achieving carbon-neutral operations across its portfolio for five consecutive years. With over six megawatts of solar energy produced at their properties, Kilroy remains a leader in sustainable real estate operations.

Looking Ahead: 2025 Guidance

Looking forward, management has provided guidance suggesting Nareit FFO for the entire year 2025 will be between $3.85 to $4.05 per diluted share. This projection considers several factors relating to operational costs, development expenses, and potential market fluctuations.

Frequently Asked Questions

What were Kilroy Realty's revenues for the fourth quarter of 2024?

Kilroy reported revenues of $286.4 million for the fourth quarter of 2024.

How did net income change in 2024?

The net income available to common stockholders increased to $59.5 million for the fourth quarter, compared to $47.3 million in the previous year.

What is Kilroy Realty's commitment to sustainability?

Kilroy has been recognized for achieving carbon-neutral operations across its portfolio and actively promotes sustainable practices.

What are the leasing activity results for 2024?

Kilroy signed approximately 1,778,000 square feet of leases in 2024, the highest level since 2019.

What does Kilroy expect for its 2025 financial guidance?

Kilroy anticipates a Nareit FFO between $3.85 and $4.05 per diluted share for the year 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 16

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Futures: George Weiss Supports Say Yes Expansion

Updated Category News Views 222

Empowering Futures Through Education As a prominent philanthropist and former hedge fund manager, George Weiss continues to advocate for transformative education initiatives. His recent support for the expansion of the Say Yes Buffalo program into Niagara Falls is a testament to his lifelong commitment to ensuring that students have access to higher education and...

Continue Reading
Dierks Bentley Unveils ROW 94 Full Proof Bourbon Delight

Updated Category News Views 217

Introducing ROW 94 Full Proof Bourbon by Dierks Bentley The Full-Throttle, Already Gold Medal-Winner is ROW 94's Third Expression. Country music superstar Dierks Bentley is thrilled to launch the boldest and most authentic bourbon in the ROW 94 lineup, known as ROW 94 Full Proof. Available for $54.99 per 750ml, this exciting new release comes just a year after the...

Continue Reading
ReShape Lifesciences Implements 1-for-58 Stock Consolidation Strategy

Updated Category News Views 61

ReShape Lifesciences Announces 1-for-58 Stock Consolidation Strategy In an effort to strengthen its presence in the market, ReShape Lifesciences Inc. (NASDAQ: RSLS), a frontrunner in weight loss and metabolic health solutions, has revealed a 1-for-58 reverse stock split of its common shares. This move, which has been approved by the company’s Board of Directors, will go...

Continue Reading
Join the Movement: Protect Your Rights as an AMLX Investor

Updated Category News Views 87

Understanding Shareholder Rights As a shareholder of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), it’s imperative to be aware of your rights and the actions you can take to safeguard your interests. With the ever-evolving landscape of corporate governance, understanding the power of your voice becomes crucial. Immediate action is often necessary, as there may be limited...

Continue Reading
Troilus Gold Secures $35 Million for Project Advancement

Updated Category News Views 271

Troilus Gold Corp. Secures $35 Million Loan Facility Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) has successfully finalized a loan agreement, securing a principal amount of up to US$35 million, approximately CDN$49 million, to bolster its development efforts. This financial support is aimed at facilitating a variety of pre-development activities, including...

Continue Reading